iSpecimen
Tracked across 2 events · 12 articles · First seen Aug 06, 2026 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
iSpecimen Inc., an online marketplace for human biospecimens, priced and closed a public offering of approximately $5 million, consisting of common stock and pre-funded warrants at $1.30 per share. The offering closed on August 7,…
Impact: iSpecimen is the issuer of the offering, raising approximately $5 million to repay liabilities and fund operations. The capital raise supports its business continuity and growth plans.
Aug 06, 2026 · 6 articles
Business
iSpecimen, a provider of human biospecimens, announced the successful completion of a large-scale international cancer research project. The project involved sourcing and shipping hundreds of cancer blood specimens within three weeks of receiving the purchase…
Impact: iSpecimen is the central entity, completing the international cancer research project and showcasing its operational capabilities. This success may strengthen its market position and attract future business.
Aug 20, 2026 · 6 articles
100
iSpecimen priced public offeringiSpecimen $5M Public Offering
70
iSpecimen completed international cancer research projectiSpecimen completes...
60
EF Hutton acted as placement agent iSpecimeniSpecimen $5M Public Offering
ERGEN INTELLIGENCE
Track iSpecimen live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard